tradingkey.logo

Mesa Laboratories Inc

MLAB
查看詳細走勢圖
80.470USD
-0.200-0.25%
收盤 12/26, 16:00美東報價延遲15分鐘
443.45M總市值
虧損本益比TTM

Mesa Laboratories Inc

80.470
-0.200-0.25%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.25%

5天

-0.70%

1月

-0.05%

6月

-18.45%

今年開始到現在

-38.98%

1年

-39.52%

查看詳細走勢圖

TradingKey Mesa Laboratories Inc股票評分

單位: USD 更新時間: 2025-12-26

操作建議

Mesa Laboratories Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名48/207位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價95.00。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Mesa Laboratories Inc評分

相關信息

行業排名
48 / 207
全市場排名
148 / 4563
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 3 分析師
買入
評級
95.000
目標均價
+21.84%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Mesa Laboratories Inc亮點

亮點風險
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
估值合理
公司最新PE估值-259.61,處於3年歷史合理位
機構減倉
最新機構持股5.12M股,環比減少12.36%
PRFDX持倉
明星投資者PRFDX持倉,最新持倉1.89K股
活躍度降低
近期活躍度降低,過去20天平均換手率1.06

Mesa Laboratories Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Mesa Laboratories Inc簡介

Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
公司代碼MLAB
公司Mesa Laboratories Inc
CEOOwens (Gary M)
網址https://mesalabs.com

常見問題

Mesa Laboratories Inc(MLAB)的當前股價是多少?

Mesa Laboratories Inc(MLAB)的當前股價是 80.470。

Mesa Laboratories Inc 的股票代碼是什麼?

Mesa Laboratories Inc的股票代碼是MLAB。

Mesa Laboratories Inc股票的52週最高點是多少?

Mesa Laboratories Inc股票的52週最高點是155.120。

Mesa Laboratories Inc股票的52週最低點是多少?

Mesa Laboratories Inc股票的52週最低點是55.450。

Mesa Laboratories Inc的市值是多少?

Mesa Laboratories Inc的市值是443.45M。

Mesa Laboratories Inc的淨利潤是多少?

Mesa Laboratories Inc的淨利潤為-1.97M。

現在Mesa Laboratories Inc(MLAB)的股票是買入、持有還是賣出?

根據分析師評級,Mesa Laboratories Inc(MLAB)的總體評級為買入,目標價格為95.000。

Mesa Laboratories Inc(MLAB)股票的每股收益(EPS TTM)是多少

Mesa Laboratories Inc(MLAB)股票的每股收益(EPS TTM)是-0.310。
KeyAI